# Everolimus

NDC: 72319-016
Generic name: everolimus
Labeler / Manufacturer: i3 Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20260807

FDA application: ANDA219464

## Active ingredients

- EVEROLIMUS: .75 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72319-016"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72319-016
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be5da0fd-8fd4-4f84-a307-f270048d503c